Gastroparesis: a turning point in understanding and treatment
Year: 2019
Type: review
Abstract: Gastroparesis is defined by delayed gastric emptying (GE) and symptoms of nausea, vomiting, bloating, postprandial fullness, early satiety and abdominal pain. Most common aetiologies include diabetes, postsurgical and postinfectious, but in many cases it is idiopathic. Clinical presentation and natural history vary by the aetiology. There is significant morbidity and healthcare utilisation associated with gastroparesis. Mechanistic studies from diabetic animal models of delayed GE as well as human full-thickness biopsies have significantly advanced our understanding of this disorder. An innate immune dysregulation and injury to the interstitial cells of Cajal and other components of the enteric nervous system through paracrine and oxidative stress mediators is likely central to the pathogenesis of gastroparesis. Scintigraphy and 13 C breath testing provide the most validated assessment of GE. The stagnant gastroparesis therapeutic landscape is likely to soon see significant changes. Relatively newer treatment strategies include antiemetics (aprepitant), prokinetics (prucalopride, relamorelin) and fundic relaxants (acotiamide, buspirone). Endoscopic pyloromyotomy appears promising over the short term, especially for symptoms of nausea and vomiting. Further controlled trials and identification of the appropriate subgroup with pyloric dysfunction and assessment of long-term outcomes are essential. This review highlights the clinical presentation, diagnosis, mechanisms and treatment advancements for gastroparesis.
Source: Gut
Institutions: Mayo Clinic, University of Bologna
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: gastroparesis, delayed gastric emptying, diabetes mellitus, idiopathic gastroparesis, postoperative gastroparesis, innate immune dysregulation, interstitial cells of Cajal, enteric nervous system, oxidative stress, scintigraphy, 13C breath test, prokinetic agents, acotiamide, buspirone, aprepitant, endoscopic pyloromyotomy, pyloric dysfunction, nausea and vomiting
Open Access status: green
Awards: Gastroparesis Consortium Continuation-Data Coordinating Center, Pathobiology of the Enteric System, Mechanisms of barrier dysfunction in post-infection irritable bowel syndrome, G8728375898, "Barrier function alterations in post-infectious irritable bowel syndrome", Continuation of the Scientific Data Research Center (SDRC) of the Gastroparesis Clinical Research Consortium (GpCRC) 4, Calcium Dynamics in Interstitial Cells of Cajal
OpenAlex ID: W2975756653
